journal article·2015-09Open access

Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II

Jonathan M. Page, Alyssa R. Merkel, Nazanin S. Ruppender, Ruijing Guo, Ushashi C. Dadwal, Shellese A. Cannonier, Sandip Basu, Scott A. Guelcher, Julie A. Sterling

Biomaterials· Volume 64

Abstract

Cancer patients frequently develop skeletal metastases that significantly impact quality of life. Since bone metastases remain incurable, a clearer understanding of molecular mechanisms regulating skeletal metastases is required to develop new therapeutics that block establishment of tumors in bone. While many studies have suggested that the microenvironment contributes to bone metastases, the factors mediating tumors to progress from a quiescent to a bone-destructive state remain unclear. In this study, we hypothesized that the "soil" of the bone microenvironment, specifically the rigid mineralized extracellular matrix, stimulates the transition of the tumor cells to a bone-destructive phenotype. To test this hypothesis, we synthesized 2D polyurethane (PUR) films with elastic moduli ranging from the basement membrane (70 MPa) to cortical bone (3800 MPa) and measured expression of genes associated with mechanotransduction and bone metastases. We found that expression of Integrin β3 (Iβ3), as well as tumor-produced factors associated with bone destruction (Gli2 and parathyroid hormone related protein (PTHrP)), significantly increased with matrix rigidity, and that blocking Iβ3 reduced Gli2 and PTHrP expression. To identify the mechanism by which Iβ3 regulates Gli2 and PTHrP (both are also known to be regulated by TGF-β), we performed Förster resonance energy transfer (FRET) and immunoprecipitation, which indicated that Iβ3 co-localized with TGF-β Receptor Type II (TGF-β RII) on rigid but not compliant films. Finally, transplantation of tumor cells expressing Iβ3 shRNA into the tibiae of athymic nude mice significantly reduced PTHrP and Gli2 expression, as well as bone destruction, suggesting a crucial role for tumor-produced Iβ3 in disease progression. This study demonstrates that the rigid mineralized bone matrix can alter gene expression and bone destruction in an Iβ3/TGF-β-dependent manner, and suggests that Iβ3 inhibitors are a potential therapeutic approach for blocking tumor transition to a bone destructive phenotype.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Bone health and treatments · Cellular Mechanics and Interactions · Bone Metabolism and Diseases

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (56)

Show source-provided references
1. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis10.1172/JCI118947 ↗
2. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients10.1200/JCO.2000.18.1.80 ↗
3. Metastasis: Metastasis to bone: causes, consequences and therapeutic opportunities10.1038/nrc867 ↗
4. Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease10.1016/j.ejca.2010.02.041 ↗
5. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival10.1073/pnas.0409462102 ↗
6. Molecular basis of metastasis10.1056/NEJMra0805239 ↗
7. Genes that mediate breast cancer metastasis to lung10.1038/nature03799 ↗
8. Gene expression profiling predicts clinical outcome of breast cancer10.1038/415530a ↗
9. Gene expression profiles of primary breast tumors maintained in distant metastases10.1073/pnas.2634067100 ↗
10. Selection of bone metastasis seeds by mesenchymal signals in the primary tumor stroma10.1016/j.cell.2013.07.036 ↗
11. Breast cancer bone metastases: it's all about the neighborhood10.1016/j.cell.2013.08.020 ↗
12. Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites
13. Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer
14. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells10.1158/0008-5472.CAN-06-0452 ↗
15. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development10.1172/JCI3523 ↗
16. Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells10.1371/journal.pone.0015451 ↗
17. Bone structural components regulating sites of tumor metastasis10.1007/s11914-011-0052-5 ↗
18. Contribution of bone tissue modulus to breast cancer metastasis to bone10.1007/s12307-011-0078-3 ↗
19. Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity10.1002/cm.20472 ↗
20. Mechanical control of integrin-mediated adhesion and signaling10.1016/j.ceb.2012.07.002 ↗
21. Stretchy proteins on stretchy substrates: the important elements of integrin-mediated rigidity sensing10.1016/j.devcel.2010.07.018 ↗
22. Is the mechanical activity of epithelial cells controlled by deformations or forces?10.1529/biophysj.105.071217 ↗
23. Rigidity sensing at the leading edge through alphavbeta3 integrins and RPTPalpha10.1529/biophysj.105.072462 ↗
24. Tissue cells feel and respond to the stiffness of their substrate10.1126/science.1116995 ↗
25. Differential matrix rigidity response in breast cancer cell lines correlates with the tissue tropism10.1371/journal.pone.0006361 ↗
26. Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells10.1186/bcr1524 ↗
27. Models of bone metastasis
28. The combined effect of tumor-produced parathyroid hormone-related protein and transforming growth factor-alpha enhance hypercalcemia in vivo and bone resorption in vitro
29. Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells10.1371/journal.pone.0015451 ↗
30. An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation10.1557/JMR.1992.1564 ↗
31. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling10.1016/S0092-8674(02)00935-2 ↗
32. Altering adsorbed proteins or cellular gene expression in MDA-MB-231 cells aeffects PTHrP and Gli2 without altering cell growth
33. Matrix crosslinking forces tumor progression by enhancing integrin signaling10.1016/j.cell.2009.10.027 ↗
34. A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells10.1242/jcs.02436 ↗
35. Cilengitide inhibits metastatic bone colonization in a nude rat model
36. Mechanism of blebbistatin inhibition of myosin II10.1074/jbc.M405319200 ↗
37. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development10.1172/JCI3523 ↗
38. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases10.1158/0008-5472.CAN-06-4499 ↗
39. Cell tension, matrix mechanics, and cancer development10.1016/j.ccr.2005.08.009 ↗
40. Tensional homeostasis and the malignant phenotype10.1016/j.ccr.2005.08.010 ↗
41. Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium10.1038/nmat4009 ↗
42. Physical and chemical microenvironmental cues orthogonally control the degree and duration of fibrosis-associated epithelial-to-mesenchymal transitions10.1002/path.4114 ↗
43. Bone metastasis: can osteoclasts be excluded?10.1038/nature05657 ↗
44. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone10.1158/0008-5472.CAN-09-1541 ↗
45. beta1- and alphav-class integrins cooperate to regulate myosin II during rigidity sensing of fibronectin-based microenvironments10.1038/ncb2747 ↗
46. Fibroblast expression of alpha-smooth muscle actin, alpha2beta1 integrin and alphavbeta3 integrin: influence of surface rigidity10.1016/j.yexmp.2011.04.007 ↗
47. Transforming growth factor beta induces clustering of HER2 and integrins by activating Src-focal adhesion kinase and receptor association to the cytoskeleton10.1158/0008-5472.CAN-08-2649 ↗
48. Src phosphorylates Tyr284 in TGF-beta type II receptor and regulates TGF-beta stimulation of p38 MAPK during breast cancer cell proliferation and invasion10.1158/0008-5472.CAN-06-3851 ↗
49. Platelet and osteoclast beta3 integrins are critical for bone metastasis10.1073/pnas.2234372100 ↗
50. Integrins and bone metastasis: integrating tumor cell and stromal cell interactions10.1016/j.bone.2010.09.016 ↗
51. Integrins as therapeutic targets10.1016/j.tips.2012.04.002 ↗
52. Cilengitide targeting of alpha(v)beta(3) integrin receptor synergizes with radioimmunotherapy to increase efficacy and apoptosis in breast cancer xenografts
53. Cilengitide treatment of newly diagnosed glioblastoma patients does not alter patterns of progression10.1007/s11060-014-1365-x ↗
54. Antibody targeting of TGF-beta in cancer patients10.2174/138920111798808392 ↗
55. Anti-transforming growth factor ss antibody treatment rescues bone loss and prevents breast cancer metastasis to bone10.1371/journal.pone.0027090 ↗
56. TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases10.1158/0008-5472.CAN-10-2651 ↗